Performance of the 32 mm Myval transcatheter heart valve for treatment of aortic stenosis in patients with extremely large aortic annuli in real‐world scenario: First global, multicenter experience
Catheterization and Cardiovascular Interventions2023Vol. 102(7), pp. 1364–1375
Citations Over TimeTop 10% of 2023 papers
Andreas Holzamer, Francesco Bedogni, Pieter van Wyk, Parag Barwad, Marcin Protasiewicz, Alfonso Ielasi, Luis Nombela‐Franco, Tim Seidler, Michael Hilker
Abstract
The Myval 32 mm prosthesis showed promising initial results in a cohort of patients who previously had to be excluded from TAVR. It is desirable that all future TAVR systems accommodate larger anatomy to allow optimal treatment of all patients.
Related Papers
- → Impact of Aortic Annulus Size on Valve Hemodynamics and Clinical Outcomes After Transcatheter and Surgical Aortic Valve Replacement(2014)125 cited
- → Aortic Valve Replacement With Patch Enlargement of the Aortic Annulus(1997)157 cited
- → Early and late outcomes of AVR with aortic annular enlargement in octogenarian(2015)10 cited
- → EFFICACY OF AORTIC VALVE REPLACEMENT USING THE St. Jude Medical-HP VALVE FOR PATIENTS WITH A SMALL AORTIC ANNULUS(2000)
- → Commentary: Sizing Up the Future?(2020)